Bridging the Gap Between Innovation and Capital
OrbiMed Advisors
Focus on therapeutic companies
Program
Any applications received before July 10, 2024 have been archived. If you submitted an application before this date, you need to reapply if you are still interested in being considered for upcoming programs. Upon completion, you will receive a link to update your form as your company grows and evolves. Applications are received on a rolling basis and considered for each month’s featured investor. There is no need to submit new applications or re-apply for specific months.
Calling all therapeutics companies!
OrbiMed is a global, multi-stage healthcare investment firm. Its private investment strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders.
Event
LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with OrbiMed.
Applications will be selected based on meeting the following criteria:
Geography:
Not restricted.
Company type:
Therapeutics companies; late preclinical or clinical stage.
Areas of Interest:
- Therapeutics
- Human
- Therapeutic modalities of interest include, (but not limited to):
- Small Molecules
- Biologics
- Genetic Medicines
- Research areas of interest include, (but not limited to):
- Oncology
- Immunology
- Cardiovascular
- Renal
Stage:
Companies seeking Series A, Series B or later funding.
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.